
Our study investigates the molecular effects elicited by the vitamin D derivative calcitriol in patients with breast cancer (BC). We showed that ERRα deregulated calcitriol/VDR‐dependent transcription, causing estrogen pathway activation and upregulation of the calcitriol degradation enzyme CYP24A1. We identified the ERRα/VDR‐interacting proteins by bioinformatics analysis and further demonstrated that simultaneous overexpression of VDR, CYP24A1, and ERRα correlated with poor prognosis in patients with basal‐like BC.
Like
Save
Share